{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.88G>C",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "C",
            "position": "88"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation in alpha-synuclein (aS)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005180"
  },
  "Experiment Method": [
    {
      "Assay Method": "Hydrogen/Deuterium Exchange coupled to NMR Spectroscopy",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "15N isotope labeled wt and A30P aS",
        "Description": "15N isotope labeled recombinant wt and A30P aS were expressed and purified from E. Coli."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.88G>C",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "The A30P mutation does not cause changes in the number, location, and overall arrangement of beta-strands in amyloid fibrils of alpha-synuclein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type aS was used as a reference for comparison with A30P mutant."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Single exponential curve fitting was used to analyze back-exchange profiles."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Deuterium incorporation levels similar to wild-type aS, indicating no significant structural change.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant deviation in deuterium incorporation levels compared to wild-type aS, indicating structural changes.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "High-Resolution Magic Angle Spinning (HR-MAS) NMR Spectroscopy",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "15N isotope labeled wt and A30P aS",
        "Description": "15N isotope labeled recombinant wt and A30P aS were expressed and purified from E. Coli."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.88G>C",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "HR-MAS NMR showed that several residues within the fibrillar core retain nano-second dynamics, with no significant structural differences induced by the A30P mutation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type aS was used as a reference for comparison with A30P mutant."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Chemical shift differences and peak intensities similar to wild-type aS, indicating no significant structural change.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant deviation in chemical shift differences or peak intensities compared to wild-type aS, indicating structural changes.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Electron Microscopy",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "wt and A30P aS fibrils",
        "Description": "aS fibrils were prepared on a glow-discharged carbon foil and stained with 1% uranyl acetate."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.88G>C",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "Electron microscopy showed a morphology characteristic of amyloid fibrils with no significant differences between wild-type and A30P aS."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type aS was used as a reference for comparison with A30P mutant."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Morphology characteristic of amyloid fibrils, similar to wild-type aS.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant deviation in fibril morphology compared to wild-type aS.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Thioflavin T Fluorescence Assay",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "wt and A30P aS",
        "Description": "Protein solutions were prepared in 20 mM Tris-HCl (pH 7.5 at 25 C), 100 mM NaCl and 0.02% NaN3 with protein concentrations of approximately 100 ÂµM."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.88G>C",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Thioflavin T fluorescence was used to monitor fibrillization, but specific results for A30P variant compared to wild-type were not detailed in the context of structural differences."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type aS was used as a reference for comparison with A30P mutant."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Fluorescence levels indicative of amyloid fibril formation, similar to wild-type aS.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant deviation in fluorescence levels compared to wild-type aS, indicating altered fibrillization kinetics.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}